close

Eris down 4% in 2 days post acquisition of 9 derma brands from Dr Reddy's

Eris Life said that the transaction would help augment and expand cosmetic dermatology business of the company through their product offerings

SI Reporter Business Standard Mumbai
Eris Lifesciences
Premium

.

Shares of Eris Lifesciences declined 2 per cent to hit two-year low of Rs 570 in Friday’s intra-day trade. The stock fell 4 per cent in two days after the company acquired nine dermatology brands from
Or

Also Read

Eris Lifesciences buys dermatology brands from Dr Reddy's for Rs 275 crore

Stocks to watch: TCS, Patanjali Foods, Glenmark Pharma, Vi, DLF, Eris Life

Trading Strategies in Bandhan Bank, Eris Lifesciences by Mehul Kothari

Pharma firms with India focus preferred as US market concerns grow

MARKET LIVE: Sensex off day's high, up 250pts; Nifty50 below 17,100

Sterling Tools hits 5-year high, surges 10% on strong business outlook

TCS down 1%, hits 4-month low day after CEO & MD Rajesh Gopinathan resigns

MARKET LIVE: Sensex off day's high, up 250pts; Nifty50 below 17,100

Stocks to watch: TCS, Patanjali Foods, Glenmark Pharma, Vi, DLF, Eris Life

NSE, BSE remove 3 Adani group stocks from short-term surveillance

ERIS Lifescience

  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 5Y

First Published: Mar 17 2023 | 10:42 AM IST

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers. Already a BS Premium subscriber?LOGIN NOW

Register to read more on Business-Standard.com